Insights into the mechanisms of histamine-induced inflammation in the nasal mucosa

Pulmonary Pharmacology and Therapeutics

Volumn 21, Issue 3, 2008, Pages 455-460

  Taylor Clark, Thomas E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA METHYLHISTAMINE; BETAHISTINE; BRADYKININ; CETIRIZINE; CLOBENPROPIT; CORYNANTHINE; DESLORATADINE; DIPHENHYDRAMINE; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; THIOPERAMIDE;

ARTICLE; HUMAN; INFLAMMATION; INTROSPECTION; NONHUMAN; NOSE INFLAMMATION; NOSE MUCOSA; PRIORITY JOURNAL; SYMPTOM;

ANIMALS; HISTAMINE; HUMANS; INFLAMMATION; NASAL MUCOSA; RECEPTORS, HISTAMINE H1; RECEPTORS, HISTAMINE H2; RECEPTORS, HISTAMINE H3;

EID: 43049087029     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2007.08.002     Document Type: Article

References (37)

1. Namimatsu A., Go K., Tanimoto H., and Okuda M. Mechanism of nasal secretion mediated via nerve reflex in guinea pigs and evaluation of antiallergic drugs. Int Arch Allergy Immunol 97 (1992) 139-145
2. Philip G., Jankowski R., Baroody F.M., Naclerio R.M., and Togias A.G. Reflex activation of nasal secretion by unilateral inhalation of cold dry air. Am Rev Respir Dis 148 (1993) 1616-1622
3. Bickford L., Shakib S., and Taverner D. The nasal airways response in normal subjects to oxymetazoline spray: randomized double-blind placebo-controlled trial. Br J Clin Pharmacol 48 (1999) 53-56
4. Baraniuk J.N., Silver P.B., Kaliner M.A., and Barnes P.J. Neuropeptide Y is a vasoconstrictor in human nasal mucosa. J Appl Physiol 73 (1992) 1867-1872
5. Okuda M., Ohnishi M., and Ohtsuka H. The effects of cromolyn sodium on the nasal mast cells. Ann Allergy 55 (1985) 721-723
6. Naclerio R.M., Meier H.L., Kagey-Sobotka A., Adkinson Jr. N.F., Meyers D.A., Norman P.S., et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 128 (1983) 597-602
7. Doyle W.J., Boehm S., and Skoner D.P. Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy. J Allergy Clin Immunol 86 (1990) 924-935
8. Miadonna A., Tedeschi A., Leggieri E., Lorini M., Folco G., Sala A., et al. Behavior and clinical relevance of histamine and leukotrienes C4 and B4 in grass pollen-induced rhinitis. Am Rev Respir Dis 136 (1987) 357-362
9. Taylor-Clark T., Sodha R., Warner B., and Foreman J. Histamine receptors that influence blockage of the normal human nasal airway. Br J Pharmacol (2005)
10. Nakaya M., Takeuchi N., and Kondo K. Immunohistochemical localization of histamine receptor subtypes in human inferior turbinates. Ann Otol Rhinol Laryngol 113 (2004) 552-557
11. Shelton D., and Eiser N. Histamine receptors in the human nose. Clin Otolaryngol Allied Sci 19 (1994) 45-49
12. Cole P., Haight J.S., Cooper P.W., and Kassel E.E. A computed tomographic study of nasal mucosa: effects of vasoactive substances. J Otolaryngol 12 (1983) 58-60
13. Chang J.Y., Hardebo J.E., and Owman C. Differential vasomotor action of noradrenaline, serotonin, and histamine in isolated basilar artery from rat and guinea-pig. Acta Physiol Scand 132 (1988) 91-102
14. Ortiz J.L., Labat C., Norel X., Gorenne I., Verley J., and Brink C. Histamine receptors on human isolated pulmonary arterial muscle preparations: effects of endothelial cell removal and nitric oxide inhibitors. J Pharmacol Exp Ther 260 (1992) 762-767
15. Toda N., and Okamura T. Endothelium-dependent and -independent responses to vasoactive substances of isolated human coronary arteries. Am J Physiol 257 (1989) H988-H995
16. Dear J.W., Ghali S., and Foreman J.C. Attenuation of human nasal airway responses to bradykinin and histamine by inhibitors of nitric oxide synthase. Br J Pharmacol 118 (1996) 1177-1182
17. McLean J.A., Bacon J.R., Mathews K.P., Banas J., Capati D., and Bayne N.K. Effects of aspirin on nasal responses in atopic subjects. J Allergy Clin Immunol 72 (1983) 187-192
18. Taylor-Clark T., and Foreman J. Histamine-mediated mechanisms in the human nasal airway. Curr Opin Pharmacol 5 (2005) 214-220
19. Gillard M., Christophe B., Wels B., Peck M., Massingham R., and Chatelain P. H1 antagonists: receptor affinity versus selectivity. Inflamm Res 52 Suppl. 1 (2003) S49-S50
20. Schroeder J.T., Schleimer R.P., Lichtenstein L.M., and Kreutner W. Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine. Clin Exp Allergy 31 (2001) 1369-1377
21. Hunter D.D., and Dey R.D. Identification and neuropeptide content of trigeminal neurons innervating the rat nasal epithelium. Neuroscience 83 (1998) 591-599
22. Dinh Q.T., Groneberg D.A., Mingomataj E., Peiser C., Heppt W., Dinh S., et al. Expression of substance P and vanilloid receptor (VR1) in trigeminal sensory neurons projecting to the mouse nasal mucosa. Neuropeptides 37 (2003) 245-250
23. Taylor-Clark T.E., Kollarik M., MacGlashan Jr. D.W., and Undem B.J. Nasal sensory nerve populations responding to histamine and capsaicin. J Allergy Clin Immunol 116 (2005) 1282-1288
24. Plevkova J., Brozmanova M., Pecova R., and Tatar M. Effects of intranasal capsaicin challenge on cough reflex in healthy human volunteers. J Physiol Pharmacol 55 Suppl 3 (2004) 101-106
25. Philip G., Baroody F.M., Proud D., Naclerio R.M., and Togias A.G. The human nasal response to capsaicin. J Allergy Clin Immunol 94 (1994) 1035-1045
26. Paus R., Schmelz M., Biro T., and Steinhoff M. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest 116 (2006) 1174-1186
27. Nilsson H.J., Levinsson A., and Schouenborg J. Cutaneous field stimulation (CFS): a new powerful method to combat itch. Pain 71 (1997) 49-55
28. Toth-Kasa I., Jancso G., Bognar A., Husz S., and Obal Jr. F. Capsaicin prevents histamine-induced itching. Int J Clin Pharmacol Res 6 (1986) 163-169
29. Wood-Baker R., Lau L., and Howarth P.H. Histamine and the nasal vasculature: the influence of H1 and H2-histamine receptor antagonism. Clin Otolaryngol Allied Sci 21 (1996) 348-352
30. Holmberg K., Pipkorn U., Bake B., and Blychert L.O. Effects of topical treatment with H1 and H2 antagonists on clinical symptoms and nasal vascular reactions in patients with allergic rhinitis. Allergy 44 (1989) 281-287
31. 2 antagonists on nasal symptoms and mediator release in atopic patients after nasal allergen challenge during the pollen season. Acta Otolaryngol 116 (1996) 91-96
32. 3 receptor blockade produces nasal decongestion in an experimental model of nasal congestion. Am J Rhinol 13 (1999) 391-399
33. 3 receptors in human nasal mucosa inhibits sympathetic vasoconstriction. Eur J Pharmacol 484 (2004) 83-89
34. 3 receptor activation inhibits neurogenic sympathetic vasoconstriction in porcine nasal mucosa. Eur J Pharmacol 452 (2002) 339-345
35. Whittet H.B., and Fisher E.W. Nasal obstruction after cervical sympathectomy: Horner's syndrome revisited. ORL J Otorhinolaryngol Relat Spec 50 (1988) 246-250
36. Kirby R.S. Clinical pharmacology of alpha1-adrenoceptor antagonists. Eur Urol 36 Suppl. 1 (1999) 48-53 [discussion 65]
37. Malm L, Okuda M, Dieges PH. Direct and reflex actions of biochemical mediators. In: Mygind N, Pipkorn U, editors. Allergic and vasomotor rhinitis: pathophysiological Aspects; 1987. p. 214-19.